League City, TX, United States of America

Barbara Olszewska-Pazdrak

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Barbara Olszewska-Pazdrak: Innovator in Endothelial Dysfunction Treatment

Introduction

Barbara Olszewska-Pazdrak is a notable inventor based in League City, TX (US). She has made significant contributions to the field of medical science, particularly in the treatment of endothelial dysfunction. Her innovative approach has the potential to impact various diseases and disorders associated with this condition.

Latest Patents

Barbara holds a patent for a method of treating endothelial dysfunction, which involves the administration of a thrombin peptide derivative. Endothelial dysfunction (ED) is linked to numerous diseases and disorders. Her research indicates that agonists of the non-proteolytically activated thrombin receptor can be utilized in methods to treat ED or ED-related diseases and disorders. This patent highlights her commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout her career, Barbara has been associated with prestigious institutions such as the University of Texas System and the Texas A&M University System. Her work in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Barbara's notable coworkers include Darrell H Carney and Theresa W Fossum. Their collaboration has likely enriched her research and expanded the impact of her innovations.

Conclusion

Barbara Olszewska-Pazdrak is a pioneering inventor whose work in treating endothelial dysfunction showcases her dedication to medical innovation. Her contributions are poised to make a significant difference in the lives of those affected by related diseases and disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…